Call Today: 800-417-9951
Contact us for free information or to start a free case review.
AvandiaŽ attorneys are the legal professionals who can help you and your loved ones of youve suffered from any injuries or illnesses while using AvandiaŽ.
Generically known as rosiglitazone, AvandiaŽ is a tablet medication prescribed to treat type-2 diabetes, a condition in which the body's resistance to insulin can endanger its blood sugar levels. AvandiaŽ is not appropriate for the treatment of type-1 diabetes, a condition in which the pancreas produces little or no insulin.
AvandiaŽ is produced by GlaxoSmithKline and should typically be taken twice daily, in the morning and the evening. AvandiaŽ can be taken with or without food.
In many cases, diabetes patients taking AvandiaŽ will, at worst, experience minor, treatable and fleeting side effects, such as:
While such health complications are typically tolerable, should they significantly impair a patient's quality of life, it's recommended that he work with his doctor to find an alternative medication to manage his type-2 diabetes.
Unfortunately, AvandiaŽ medication has been found to cause some less common, serious side effects that, in the worst cases, are life-threatening. Severe AvandiaŽ side effects have been reported to include:
Patients may be developing any of the above AvandiaŽ injuries if they start developing the following symptoms:
It's vital that AvandiaŽ patients experiencing any of the above changes in their health seek emergency medical attention to prevent further injuries and to save their lives.
Once injured AvandiaŽ pateints have received the medical attention they need, they should consider meeting with an attorney for defective drugs and products who can investigate the details of their claim and help determine whether they are eligible to file an AvandiaŽ lawsuit to seek compensation for their losses.
AvandiaŽ lawyers offer initial consultations for free to encourage injured parties to stand up for their legal rights.
To schedule a FREE consultation with an experienced AvandiaŽ attorney, contact us today.
The FDA announced that is has made a change regarding cardiovascular risks to the Avandia® (rosiglitazone) label and patient Medication Guide, Feb. 4, 2011.
The FDA announcement also said that Avandia®'s drug label was updated ...
A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.
The 10,000 patient trial was examining the effectiveness of aggressive ...
A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.
Ob...
Copyright Š 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.